Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment - Wikidata - awgldk - TriplyDB

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

http://www.wikidata.org/entity/Q35758837

about

Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report.Antibiotic therapy in aging patients.Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review.Are antibiotic drugs well prescribed in case of renal insufficiency? A retrospective study.Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples.Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.Reversible Ceftriaxone-Induced Pseudolithiasis in an Adult Patient with Maintenance Hemodialysis.Lack of probenecid effect on nonrenal excretion of ceftriaxone in anephric patients.Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation.Three Cases of Hemodialysis Patients Receiving High-Dose Ceftriaxone: Serum Concentrations and Its Neurotoxicity.Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation.

P2860

Q33406171-DEE92DDD-B1BF-4B32-BBCF-B86DAD315C4E Q35119901-F801AB2D-91EB-45A8-832F-ECA20ED76887 Q36195719-1B8F5671-6622-443C-9886-71236EEE34CA Q37027422-2DDF0329-AB72-4B0D-A673-8B4ADECD5C3B Q38369608-B39973F2-CD6C-4FF6-BE9C-F1593E023E7C Q39470313-6D52234D-F5E2-4DD3-8460-D76F4B795ABE Q39835731-BD94C180-EFF0-448D-AECE-B818E0B0A915 Q40914194-0E9C871B-5AFD-4402-BE66-C1BE7A750E2B Q44945407-D51299F9-9C93-4ED8-BC12-F5EF85CEE8F8 Q47133107-1E8D07B5-FE3B-466D-A26E-F731872DAB01 Q47134074-3B81BAA4-C837-448D-B6CE-5ED6472EFF50 Q51625200-0E3A5CD5-15DA-43AA-97C8-00BD5BD6D65B

P2860

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

http://www.wikidata.org/entity/Q35758837

description

1984 nî lūn-bûn

@nan

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

1984年论文

@zh

1984年论文

@zh-cn

name

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

@ast

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

@en

type

label

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

@ast

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

@en

prefLabel

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

@ast

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

@en

P1433

Q35758837-6210F24D-D44B-4F29-BD04-CC9782CF2822

P1476

Q35758837-EDEE3C25-AEB8-4365-8A7F-63BF07B840F2

P2093

Q35758837-0101107A-6E21-42A6-97EE-56FE4130583A

Q35758837-1A8D5C38-0044-4FCD-AFDB-3A8D5A76BC2E

Q35758837-32F5377A-0B9C-4A50-93B2-2E11A6E48EAE

Q35758837-6586E88D-74AF-4E19-94EE-D0C564F46627

Q35758837-DA9422A1-B206-4121-8C9B-E5C3CCF89B9F

Q35758837-E25BF205-BEBC-41C3-B6D2-DBBFEB675312

P2860

Q35758837-218B4668-CEB2-4B0A-B76C-7032F6D55B9A

Q35758837-248905CB-E953-441E-9CB8-C41DFE603109

Q35758837-304DFB7D-2F47-4264-B993-2E2374B82493

Q35758837-39BE11AC-629F-43C8-8284-5F2F5CABE797

Q35758837-8CDD1DF4-6A85-4366-A90A-E1E49E9C8442

Q35758837-C5C4F51E-4810-497D-B952-09A6336B2CF4

Q35758837-F0E2FB21-DF72-4ED6-9CE3-E0EAC7BDC90C

P304

Q35758837-E3467943-29CA-41D4-902A-2CDF353EB650

P31

Q35758837-809205A2-4782-4782-BF25-87D2375F7BDB

P356

Q35758837-AD29A6F3-4263-4F7F-A11D-A7A378A92382

P407

Q35758837-9ABC844B-56FE-4A1C-B991-E45E581D0EB1

P433

Q35758837-D1A2C4C9-ADD7-4F83-B4A3-7CD53A1E24F9

P478

Q35758837-A431C316-94D5-47AE-AF72-D7EC1190B607

P577

Q35758837-8B95A204-5CA8-422B-A652-3D928983648A

P698

Q35758837-F63EE188-38DC-4CB8-8544-53C756C7F0CE

P932

Q35758837-C42183BE-1458-48D7-AC83-A2FB4276D579

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

@en

P2093

Berman SJ

http://www.w3.org/2001/XMLSchema#string

Patel IH

http://www.w3.org/2001/XMLSchema#string

Siemsen AW

http://www.w3.org/2001/XMLSchema#string

Sugihara JG

http://www.w3.org/2001/XMLSchema#string

Weinfeld RE

http://www.w3.org/2001/XMLSchema#string

Wong EG

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.

Pharmacokinetics of ceftriaxone in humans.

Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.

Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.

Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

P304

438-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.25.4.438

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

1984-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6329080

http://www.w3.org/2001/XMLSchema#string

P932

185547

http://www.w3.org/2001/XMLSchema#string